DBT
SAGE icon

Dubuque Bank & Trust’s Sage Therapeutics SAGE Stock Holding History

Dubuque Bank & Trust’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,600
Closed -$224K – 201
2019
Q3 		$224K Hold
1,600
– – 0.04% 165
2019
Q2 		$293K Hold
1,600
– – 0.05% 147
2019
Q1 		$254K Hold
1,600
– – 0.04% 142
2018
Q4 		$153K Hold
1,600
– – 0.03% 171
2018
Q3 		$226K Hold
1,600
– – 0.04% 148
2018
Q2 		$250K Sell
1,600
-200
-11% -$31.4K 0.04% 161
2018
Q1 		$290K Sell
1,800
-10
-0.6% -$1.7K 0.05% 156
2017
Q4 		$298K Sell
1,810
-290
-14% -$28.1K 0.05% 167
2017
Q3 		$131K Hold
2,100
– – 0.02% 257
2017
Q2 		$167K Buy
+2,100
New +$152K 0.04% 218

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Dubuque Bank & Trust's SAGE Position: Q4 2019 in Review

Dubuque Bank & Trust sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 1,600 shares — an estimated $224K sold.

Dubuque Bank & Trust first reported a position in SAGE in Q2 2017 and held it in 10 quarters. The position peaked at $298K in Q4 2017. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • Dubuque Bank & Trust reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Dubuque Bank & Trust sold 1,600 Sage Therapeutics shares in Q4 2019, an estimated $224K.
  • Dubuque Bank & Trust first reported a position in Sage Therapeutics in Q2 2017 and held it in 10 quarters.
  • Dubuque Bank & Trust's Sage Therapeutics position peaked at $298K in Q4 2017.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Dubuque Bank & Trust's 13F filing for Q4 2019, filed 14 Jan 2020.